ID
45503
Descrizione
Principal Investigator: Geoffrey Ginsburg, MD, PhD, Institute for Genome Science and Policy, Duke University, Durham, NC, USA MeSH: Cardiovascular Diseases,Myocardial Infarction,Coronary Artery Disease https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000551 Case control cohort: The details have been previously published: American Heart Journal. 2010;160:371-379 e372. Briefly, a nested case:control cohort of CATHGEN participants who had experienced death or MI (n = 250) after their index catheterization and age-, sex-, and race-matched controls (n = 250) who were free of death/MI 2 years after cardiac catheterization was identified as part of the MURDOCK Horizon 1 Cardiovascular Disease Study.21 Sufficient RNA for microarray analysis was available in 447 members of this cohort. Observational cohort: 224 sequential CATHGEN samples were selected for whole blood RNA analysis, of which, 191 had sufficient RNA for microarray analysis.
collegamento
Keywords
versioni (2)
- 03/11/22 03/11/22 - Simon Heim
- 13/12/22 13/12/22 - Kristina Keller
Titolare del copyright
Geoffrey Ginsburg, MD, PhD, Institute for Genome Science and Policy, Duke University, Durham, NC, USA
Caricato su
13 dicembre 2022
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
dbGaP phs000551 Gene expression in CAD
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Subject ID and sample ID of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Subject ID, age, sex, race, history or transplantation, days from catheterization to death, death or myocardial infraction, coronary artery disease, hyperlipidemia, hypertension, smoking, and diabetes of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Sample ID, source of biologic sample, and analyte type of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Subject ID and sample ID of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Subject ID, age, sex, race, history or transplantation, days from catheterization to death, death or myocardial infraction, coronary artery disease, hyperlipidemia, hypertension, smoking, and diabetes of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Sample ID, source of biologic sample, and analyte type of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
C0679823 (UMLS CUI [1,2])
C1711176 (UMLS CUI [1,3])
C1608383 (UMLS CUI [1,4])
C5420592 (UMLS CUI [1,5])
C4288536 (UMLS CUI [1,6])
C0000872 (UMLS CUI [1,7])
C0030705 (UMLS CUI [1,8])
C1442880 (UMLS CUI [1,9])
C0018795 (UMLS CUI [1,10])